Advanced Manufacturing Growth Investors & VC Firms
796 firms in this list, with a median first check of $3M. 213 of them lead rounds. Generated from verified public data and updated continuously.
Altor
StockholmGrowth–Late Stage
101 people
BDC Industrial Innovation Venture Fund
MontréalSeries A–Growth
124 people
Gimv
AntwerpGrowth–Late Stage$21M – $430M
101 people
Kelso
New YorkGrowth
80 people
ChrysCapital
MumbaiGrowth
105 people
Pacific Equity Partners Pty Ltd.
SydneyGrowth–Late Stage$3.3M
111 people
Triton Partners
LondonSeed–Growth
105 people
Nautic Partners
ProvidenceGrowth$50M – $400M
84 people
Emerald Technology Ventures Ag
ZurichSeed–Late Stage$540K – $5.4M
79 people
Ridgemont Equity
CharlotteGrowth$250M
81 people
Sterling Group
HoustonGrowth$50M – $350M
84 people
Bayern Kapital
LandshutSeed–Growth$270K – $54M
47 people
SK Capital Partners
New YorkGrowth–Late Stage
95 people
Levine Leichtman
Beverly HillsGrowth
80 people
Tesi (Finnish Industry Investment Ltd)
HelsinkiSeed–Late Stage$5.4M – $16.2M
24 people
Littlejohn
GreenwichGrowth–Late Stage
80 people
MML UK Advisor
LondonGrowth$6.5M – $155M
78 people
Viking Global
StamfordGrowth–Late Stage
61 people
Business Growth Fund
LondonSeed–Growth$3.8M – $38M
71 people
Scientifica Venture Capital
L'AquilaPre-Seed–Growth
92 people
Sun Capital Partners
Boca RatonGrowth
65 people
JIC Venture Growth Investments
TokyoSeed–Growth
35 people
Beringea
LondonSeries A–Growth$3M – $10M
38 people
YFM Equity Partners
LeedsGrowth$3.8M – $19M
65 people
Related lists
Growth Investors & VC Firms (4561)Growth Investors & VC Firms in North America (2360)Advanced Manufacturing Investors & VC Firms (2063)Growth Investors & VC Firms in United States (2055)Growth Investors & VC Firms in Europe (1814)Growth Investors & VC Firms in Global (1565)Healthtech Growth Investors & VC Firms (1464)Advanced Manufacturing Seed Investors & VC Firms (1408)Fintech Growth Investors & VC Firms (1400)Growth Investors & VC Firms in Asia-Pacific (1343)
Data sourced from public filings and firms' own websites — see our methodology.









































































































